Pulmonary immune responses against SARS-CoV-2 infection: harmful or not?

Guillon, A; Hiemstra, P S; Si-Tahar, M

Guillon, A; Hiemstra, P S; Si-Tahar, M.

Guillon A; Intensive Care Unit, Tours University Hospital, 2 Bd Tonnellé, 37044, Tours Cedex 9, France. antoine.guillon@univ-tours.fr.
Hiemstra PS; University of Tours, Tours, France. antoine.guillon@univ-tours.fr.
Si-Tahar M; Research Center for Respiratory Diseases, INSERM U1100, Tours, France. antoine.guillon@univ-tours.fr.

Intensive Care Med ; 46(10): 1897-1900, 2020 10.

Article in English | MEDLINE | ID: covidwho-653822

Subject(s)

Coronavirus Infections; Pandemics; Pneumonia, Viral; Severe Acute Respiratory Syndrome; Betacoronavirus; COVID-19; Humans; Immune Evasion; RNA; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Severe Acute Respiratory Syndrome / Pandemics Limits: Humans Language: English Journal: Intensive Care Med Year: 2020 Document Type: Article Affiliation country: S00134-020-06170-8

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google